Identification of three major sentrinization sites in PML

被引:278
作者
Kamitani, T [1 ]
Kito, K [1 ]
Nguyen, HP [1 ]
Wada, H [1 ]
Fukuda-Kamitani, T [1 ]
Yeh, ETH [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Internal Med,Res Ctr Cardiovasc Dis, Div Mol Med,Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA
关键词
D O I
10.1074/jbc.273.41.26675
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute promyelocytic leukemia arises following a reciprocal chromosome translocation t(15;17), which generates PML-retinoic acid receptor alpha fusion proteins (PML-RAR alpha). We have shown previously that wild type PML, but not PML-RAR alpha, is covalently modified by the sentrin family of ubiquitin-like proteins (Kamitani, T., Nguyen, H. P., Kito, K., Fukuda-Kamitani, T., and Yeh, E. T. H. (1998) J. Biol. Chem. 273, 3117-3120). To understand the mechanisms underlying the differential sentrinization of PML versus PML-RAR alpha, extensive mutational analysis was carried out to determine which Lys residues are sentrinized, We show that Lys(65) in the RING finger domain, Lys(160) in the B1 Box, and Lys(490) in the nuclear localization signal contributes three major sentrinization sites. The PML mutant with Lys to Arg substitutions in all three sites is expressed normally, but cannot be sentrinized. Furthermore, the triple substitution mutant is localized predominantly to the nucleoplasm, in contrast to wild type PML, which is localized to the nuclear bodies. Thus, sentrinization of PML, in the context of the RING finger and the BI box, regulates nuclear body formation. Furthermore, we showed that sentrinization of PML-RAR alpha could be restored by overexpression of sentrin, but not by retinoic acid treatment. These studies provide novel insight into the pathobiochemistry of acute promyelocytic leukemia and the sentrinization pathway.
引用
收藏
页码:26675 / 26682
页数:8
相关论文
共 44 条
[31]   A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2 [J].
Mahajan, R ;
Delphin, C ;
Guan, TL ;
Gerace, L ;
Melchior, F .
CELL, 1997, 88 (01) :97-107
[32]   Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association [J].
Mahajan, R ;
Gerace, L ;
Melchior, F .
JOURNAL OF CELL BIOLOGY, 1998, 140 (02) :259-270
[33]   A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex [J].
Matunis, MJ ;
Coutavas, E ;
Blobel, G .
JOURNAL OF CELL BIOLOGY, 1996, 135 (06) :1457-1470
[34]   SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex [J].
Matunis, MJ ;
Wu, JA ;
Blobel, G .
JOURNAL OF CELL BIOLOGY, 1998, 140 (03) :499-509
[35]   PML, A GROWTH SUPPRESSOR DISRUPTED IN ACUTE PROMYELOCYTIC LEUKEMIA [J].
MU, ZM ;
CHIN, KV ;
LIU, JH ;
LOZANO, G ;
CHANG, KS .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) :6858-6867
[36]   Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus [J].
Müller, S ;
Matunis, MJ ;
Dejean, A .
EMBO JOURNAL, 1998, 17 (01) :61-70
[37]  
Okura T, 1996, J IMMUNOL, V157, P4277
[38]  
PANDOLFI PP, 1991, ONCOGENE, V6, P1285
[39]   PMLRAR HOMODIMERS - DISTINCT DNA-BINDING PROPERTIES AND HETEROMERIC INTERACTIONS WITH RXR [J].
PEREZ, A ;
KASTNER, P ;
SETHI, S ;
LUTZ, Y ;
REIBEL, C ;
CHAMBON, P .
EMBO JOURNAL, 1993, 12 (08) :3171-3182
[40]   UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins [J].
Shen, ZY ;
PardingtonPurtymun, PE ;
Comeaux, JC ;
Moyzis, RK ;
Chen, DJ .
GENOMICS, 1996, 36 (02) :271-279